Abstract
The epidemiological WHO-data for AIDS show, as we all know, that the increase of AIDS cases from the group of intravenous drug users (IVDU) is higher than in the other risk groups, and has reached a total of about one third of all cumulative reported AIDS cases in Europe (4). The vertical Virus transfer to the next generation is mainly caused by infected mothers from the group of drug users or by mothers with sexual contact to drug users. Regarding the horizontal virus transfer from the population at risk to the general population in the pattern-1-countries there is little doubt that the IVDU population is of great importance (3,7,13).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literature
Bornemann R, Bschor F, Platz W, Rex R, Püschel K, Schneider V (1990) Rückgang der HIV-1-Prävalenz bei i.v.-Drogenabhängigen in Berlin W and Hamburg: Erfolg der Prävention? 3. Deutscher AIDS-Kongreß Hamburg 24.-27. 11. 1990
Bschor F, Schneider V, Bornemann R, Püschel K (1988) Dynamics of HIV-spread amongst iv-drug addicts. Proceedings of the 35th International Congress on Alcoholism and Drug Dependence. Oslo Vol 1: 378–386
Des Jarlais DC, Friedman SR, Stoneburger RL (1988) HIV Infection and Intravenous Drug Use: Critical Issues in Transmission Dynamics, Infection Outcomes, and Prevention. Reviews of Infectious Diseases 10: 151–158
European Centre for the Epidemiological Monitoring of AIDS. AIDS Surveillance in Europe. Quarterly Report Nr 28 from 31st Dec 1990
Kaldor J (1990) Review of Australian HIV Seroprevalence Studies among Intravenous Drug Users (IVDU) DRAFT National Centre in HIV Epidemiology and Clin. Research, Faculty of Medicine, The University of New South Wales
Kleiber D (1991) Drug Addiction and AIDS in Germany. First European Symposium on Drug Addiction and AIDS, Vienna Feb 21–23 1991
Mersey Regional Health Authority Drugs and HIV Monitoring Unit (1990) HIV infection among drug injectors in England. Internat. J. Drug Policy I /4: 15–15
Newcombe R (1989) Preventing the spread of HIV infection. Internat.J Drug Policy I /2: 20–27
Puschel K, Lieske K, Laufs R, Bschor F, Schneider V, Marcus U (1988) Entwicklung der HIV-1-Antikörperprävalenz bei Rauschgifttoten in Berlin und Hamburg. AIFO 3: 452–454
Puschel K, Mohsenian F, Bornemann R, Bschor F, Schneider V, Penning R, Spann W, von Karger J, Madea B, Metter D: HIV-1-Prävalenz bei Drogentoten in verschiedenen Großstädten der Bundesrepublik Deutschland und in Westberlin zwischen 1985 und 1988. Z Rechtsmed 103: 407–414
Robertson JR, Bucknall ABV, Welsby PD, Roberts JJK, Inglis JM, Peutherer JF, Brettle RP (1986) Epidemic of AIDS related virus infection among intravenous drug users. Br Med J 292: 527–529
Rosenbrock R (1986) AIDS kann schneller besiegt werden. Gesundheitspolitik am Beispiel einer Infektionskrankheit. VSA Verlag Hamburg
Velimirowicz B (1987) AIDS und Drogenabhängigkeit aus der Sicht des Epidemiologen. AIFO 2: 323–334
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag/Wien
About this paper
Cite this paper
Bschor, F., Bornemann, R., Borowski, C., Schneider, V. (1991). Monitoring of HIV-Spread in Regional Populations of Injecting Drug Users — the Berlin Experience. In: Loimer, N., Schmid, R., Springer, A. (eds) Drug Addiction and AIDS. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9173-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9173-6_12
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82298-2
Online ISBN: 978-3-7091-9173-6
eBook Packages: Springer Book Archive